Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Cocaine Use Reduction with Buprenorphine (CURB): Rationale, Design, and Methodology

Go back to Resources

Cocaine Use Reduction with Buprenorphine (CURB): Rationale, Design, and Methodology

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Chronic Kidney Disease (CKD) After Liver Transplantation in HIV/HCV Coinfected Versus HIV/non-HCV Infected Recipients: Results from the NIH Multi-Site Study

Go back to Resources

Chronic Kidney Disease (CKD) After Liver Transplantation in HIV/HCV Coinfected Versus HIV/non-HCV Infected Recipients: Results from the NIH Multi-Site Study

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

BK and JC Polyomavirus (PyV) in HIV-1 Infected Kidney Transplant Recipients (KTR)

Go back to Resources

BK and JC Polyomavirus (PyV) in HIV-1 Infected Kidney Transplant Recipients (KTR)

Authors:

Secondary:

Location:

URL:

Abstract:

Go back to Resources

An International Ki67 Reproducibility Study

Go back to Resources

An International Ki67 Reproducibility Study

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Algorithms for Inference Following Bernoulli Random Walks with Desirable Absorbing Boundaries

Go back to Resources

Algorithms for Inference Following Bernoulli Random Walks with Desirable Absorbing Boundaries

Authors:

Secondary:

Location:

URL:

Go back to Resources

Aging Effects on Oropharyngeal Swallow and the Role of Dental Care in Oropharyngeal Dysphagia

Go back to Resources

Aging Effects on Oropharyngeal Swallow and the Role of Dental Care in Oropharyngeal Dysphagia

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Acquired Hypogammaglobulinemia in HIV Positive Subjects After Liver Transplantation

Go back to Resources

Acquired Hypogammaglobulinemia in HIV Positive Subjects After Liver Transplantation

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

A Successful Web Seminar Program for Cell Therapy: An Update from the Production Assistance for Cellular Therapies (PACT) Group

Go back to Resources

A Successful Web Seminar Program for Cell Therapy: An Update from the Production Assistance for Cellular Therapies (PACT) Group

Authors:

Secondary:

Volume:

Pagination:

Location:

Publisher:

URL:

Go back to Resources

A Successful Support Program for Cell Therapy: An Update from the Production Assistance for Cellular Therapies (PACT) Group

Go back to Resources

A Successful Support Program for Cell Therapy: An Update from the Production Assistance for Cellular Therapies (PACT) Group

Authors:

Secondary:

Volume:

Pagination:

URL:

Go back to Resources

A Lower Confidence Limit for the Benchmark Dose Using Higher Order Inference

Go back to Resources

A Lower Confidence Limit for the Benchmark Dose Using Higher Order Inference

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 205
  • Page 206
  • Page 207
  • Page 208
  • Current page 209
  • Page 210
  • Page 211
  • Page 212
  • Page 213
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification